KPNA2 and hepatocellular carcinoma: KPNA2 is upregulated in multiple types of cancer and associated with an adverse outcome of patients in breast cancer [15], CRC [16], urothelial cancer [17], etc. In HCC, the change in KPNA2 expression is not clear yet.